Nutricia is a global health company that leads the development and use of advanced medical nutrition for specialized care.
Nutricia products and services transform the daily lives of millions of infants, children, adults and aging seniors. We are dedicated to providing quality formulas and medical foods for the treatment of food protein allergies and rare genetic and metabolic disorders.
Consisting of a wide variety of FDA and Health Canada approved products the Nutricia product line is used in the management of inherited metabolic diseases, severe allergic and gastrointestinal disorders as well as other conditions requiring advanced medical nutrition for specialized care.
Nutricia was the first to offer amino acid-based, hypoallergenic formulas for the dietary management of cow milk allergy. Over time, Nutricia has diversified its product range by offering products specifically designed for intractable epilepsy and the company is researching innovative options for patients with phenylketonuria.
Our company has a world renowned research facility supported by more than 150 PhDs developing trusted and effective products for a better, healthier life. Nutricia partners with more than 50 university research centers across the globe. We are committed to clinical research and to improving and enhancing medical nutrition for specialized care through trials, studies and academic collaboration.
Nutricia North America (formerly known as SHS North America) was established in 1983 and is headquartered in Rockville, Md. Nutricia is also a part of the medical nutrition division of Groupe Danone based in Paris, France.